Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Francois Fasquelle"'
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0301687 (2024)
In the monitoring of human Toxoplasma gondii infection, it is crucial to confirm the development of a specific Th1/Th17 immune response memory. The use of a simple, specific, and sensitive assay to follow the T-cell activation is thus required. Curre
Externí odkaz:
https://doaj.org/article/de950f86e41845e4acca9246e079e7ea
Autor:
Antonia Stamatiou, Jeremy Jankovic, Petr Szturz, Francois Fasquelle, Rafael Duran, Niklaus Schaefer, Antonella Diciolla, Antonia Digklia
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Arising from the biliary tract, cholangiocarcinoma is a rare and aggressive epithelial cancer. According to the primary site, it can be further classified into intrahepatic, perihilar and distal types. Due to the lack of symptoms early in the disease
Externí odkaz:
https://doaj.org/article/b2c0c81a3076466bb8a84a194747d129
Autor:
Apostolos Sarivalasis, Liapi Aikaterini, Ana-Maria Dolcan, Sofiya Latifyan, Fernanda Herrera, Delfyne Hastir, Francois Fasquelle, Jean-Philippe Brouland, Patrice Mathevet
Publikováno v:
Ovarian cancer.
Autor:
Inès Vergez, Magloire Pandoua Nekoua, Cédric Rubrecht, François Fasquelle, Angelo Scuotto, Enagnon Kazali Alidjinou, Didier Betbeder, Didier Hober
Publikováno v:
Intervirology, Vol 67, Iss 1, Pp 99-105 (2024)
Introduction: The effect of maltodextrin-based nanoparticles with an anionic phospholipid core (lipid-based nanoparticles [NPLs]) on the infection of a human tumoral cell line with poliovirus (PV) has been studied. Methods: NPLs were synthesized and
Externí odkaz:
https://doaj.org/article/a34bd27da0f745e3926197ff6ae50633
Autor:
Daniela Ogonczyk-Makowska, François Fasquelle, Anaïs-Camille Vreulx, Angelo Scuotto, Amélie Degraeve, Bryan Thiroux, Louise Françoise Martin, Stamatios Alan Tahas, Jeanne Toft Jakobsen, Gregers Jungersen, Didier Betbeder
Publikováno v:
International Journal for Parasitology: Parasites and Wildlife, Vol 25, Iss , Pp 101017- (2024)
Toxoplasma gondii is a ubiquitous parasite causing significant mortality in captive wildlife, especially marsupials. Historically, treatment has been unrewarding and no vaccine was available. An intranasal vaccine based on purified inactivated T. gon
Externí odkaz:
https://doaj.org/article/5ba5560ddab04af382a38317f1b3b46a
Autor:
Ana Dolcan, Marie Meyer, Francois Fasquelle, Arnaud Hocquelet, Christine Sempoux, Nermin Halkic, Antonia Digklia
Publikováno v:
Cancer Reports and Reviews. 6
Autor:
François Fasquelle, Angelo Scuotto, Anaïs-Camille Vreulx, Thierry Petit, Thomas Charpentier, Didier Betbeder
Publikováno v:
International Journal for Parasitology: Parasites and Wildlife, Vol 22, Iss , Pp 69-74 (2023)
Toxoplasma gondii is an intracellular protozoon found worldwide, which completes its life cycle between felids (its definitive host) and other warm-blooded animals. While the infection rarely leads to severe complications in humans, many animal speci
Externí odkaz:
https://doaj.org/article/999b600b534d4b908def184b3a648f02
Publikováno v:
Pharmaceutics, Vol 16, Iss 2, p 247 (2024)
Nanoparticles are increasingly being studied as antigen delivery systems for immunization with nasal vaccines. The addition of adjuvants is still generally required in many nanoparticle formulations, which can induce potential side effects owing to m
Externí odkaz:
https://doaj.org/article/37952c8371034a6d99d06aee2bb4613e
Autor:
Rafael Antonio Nascimento Ramos, Alessio Giannelli, François Fasquelle, Angelo Scuotto, Didier Betbeder
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 17, Iss 5, p e0011360 (2023)
BackgroundCanine Leishmaniasis (CanL) caused by the L. infantum species is one of the biggest threats to the health of the South American canine population. Chemotherapeutics currently used for the treatment of CanL fail to induce a total parasite cl
Externí odkaz:
https://doaj.org/article/0cf749508433455e807be9adb99483be
Autor:
Solange Peters, Olivier Michielin, Michel Obeid, Darius Moradpour, Christine Sempoux, Montserrat Fraga, Hasna Bouchaab, Sofiya Latifyan, François Fasquelle, Julien Vionnet, Alexandre Wicky, Alexander Coukos, Haithem Chtioui
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 10 (2022)
Background Immune checkpoint inhibitors (ICIs) have become a mainstay of cancer treatment. Their immune-boosting quality has one major drawback, their proclivity to induce a broad array of immune-related adverse events (irAEs) affecting, among others
Externí odkaz:
https://doaj.org/article/ff2128c5eb53470b8097792b52d4c568